These data suggest that DRP1 inhibitor Mdivi-1 suppresses the in vivo growth of hypoxia-exposed HCC cells through blockage of DRP1-mediated mitophagy and increased cell apoptosis. Here, DNM1L is linked to hepatocellular carcinoma.